Skip to main content
Clinical Trials/NL-OMON50969
NL-OMON50969
Completed
Phase 4

Determining the clinical relevance of the inTeraction between AprepitaNt aNd EtoposiDe; an observational pharmacokinetic study (TANNED-study) - TANNED

Afdeling Apotheek0 sites12 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
testicular cancer
Sponsor
Afdeling Apotheek
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Afdeling Apotheek

Eligibility Criteria

Inclusion Criteria

  • Patients with TC who will start or already started treatment with (B)EP
  • Age of at least 18 years
  • Patients from whom it is possible to collect blood samples
  • Patients who are able and willing to give written informed consent prior to

Exclusion Criteria

  • Patients who are co\-treated with drugs that could interfere with the
  • metabolism of etoposide (including drugs classified as a weak, moderate or
  • strong CYP3A4 inhibitor OR weak, moderate and strong inducers of CYP3A4
  • according to the table based on the Flockhart table).

Outcomes

Primary Outcomes

Not specified

Similar Trials